Van Cleef Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-5,935
Closed -$254K 117
2021
Q2
$254K Hold
5,935
0.04% 112
2021
Q1
$229K Hold
5,935
0.04% 111
2020
Q4
$213K Sell
5,935
-265
-4% -$9.55K 0.03% 112
2020
Q3
$237K Hold
6,200
0.04% 101
2020
Q2
$218K Sell
6,200
-45
-0.7% -$1.62K 0.04% 101
2020
Q1
$204K Sell
6,245
-350
-5% -$13.7K 0.05% 98
2019
Q4
$298K Hold
6,595
0.06% 99
2019
Q3
$268K Sell
6,595
-350
-5% -$14.8K 0.06% 98
2019
Q2
$298K Hold
6,945
0.07% 96
2019
Q1
$267K Hold
6,945
0.06% 100
2018
Q4
$245K Buy
6,945
+960
+16% +$34.8K 0.07% 99
2018
Q3
$230K Sell
5,985
-2,795
-32% -$97.6K 0.05% 108
2018
Q2
$287K Sell
8,780
-120
-1% -$3.62K 0.07% 98
2018
Q1
$243K Sell
8,900
-500
-5% -$13.6K 0.06% 101
2017
Q4
$233K Hold
9,400
0.06% 100
2017
Q3
$274K Sell
9,400
-100
-1% -$2.76K 0.07% 89
2017
Q2
$263K Hold
9,500
0.08% 85
2017
Q1
$236K Hold
9,500
0.07% 89
2016
Q4
$205K Sell
9,500
-100
-1% -$2.18K 0.07% 95
2016
Q3
$228K Hold
9,600
0.08% 90
2016
Q2
$224K Buy
+9,600
New +$208K 0.08% 92

Other funds holding BSX

Van Cleef Asset Management's BSX Position: Q3 2021 in Review

Van Cleef Asset Management sold out of Boston Scientific (BSX) in Q3 2021, closing a stake of 5,935 shares — an estimated $254K sold.

Van Cleef Asset Management first reported a position in BSX in Q2 2016 and held it in 21 quarters. The position peaked at $298K in Q4 2019. 877 funds tracked by Wall St. Rank hold BSX as of Q3 2021.

  • Van Cleef Asset Management reported no remaining Boston Scientific position as of Q3 2021 after selling out during the quarter.
  • Van Cleef Asset Management sold 5,935 Boston Scientific shares in Q3 2021, an estimated $254K.
  • Van Cleef Asset Management first reported a position in Boston Scientific in Q2 2016 and held it in 21 quarters.
  • Van Cleef Asset Management's Boston Scientific position peaked at $298K in Q4 2019.
  • 877 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2021.

Based on Van Cleef Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.